Medimmune Llc

This study tested two immune-boosting drugs, durvalumab and tremelimumab, alone or together, in 433 adults with advanced liver cancer that had stopped responding to standard treatment. The goal was to see if these drugs could shrink tumors and how safe they were. While not a cure…

This study tests an experimental drug called tremelimumab against a placebo in people with advanced mesothelioma that cannot be removed by surgery. About 571 adults who have already tried at least one prior treatment will be randomly assigned to receive either the drug or a place…

This study tests new drug combinations in 43 adults with advanced EGFR-mutant non-small cell lung cancer that has been treated before. The goal is to see if these combinations are safe and can shrink tumors. Participants receive one of several experimental drug pairs, and researc…

This study tests whether adding new cancer drugs to standard chemotherapy can better control metastatic colorectal cancer that is microsatellite-stable. About 61 adults with this advanced cancer will receive different drug combinations. The main goals are to check safety and see …